NSE has sought clarification from several listed companies regarding price and volume fluctuations.

Traders Union
All News
Financial News
NSE has sought clarification from companies.

Highlights

The National Stock Exchange of India has sought clarification from Archean Chemical, CARYSIL, JITF Infralogistics, Kronox Lab Sciences, Shreedhar Spinners, and Swaraj Suiting regarding unusual price or volume movements.
Clarifications from C.E. Info Systems and Hinduja Global Solutions have been made public on the exchange's website, while Hinduja Global was sent letters regarding July 14 and 15, 2026.
NSE has asked companies to clarify facts regarding media reports related to IDBI Bank, Instamart-HPCL, Tata Motors-UCO Bank, and Zydus Cancer Drug Ikra.

This article was translated from the original. Read the original version by our correspondent here.

Exchange Clarification Process and Affected Companies

As stated in the National Stock Exchange of India press release, the exchange has sent letters to Archean Chemical Industries Limited, CARYSIL LIMITED, JITF Infralogistics Limited, Kronox Lab Sciences Limited, Shreedhar Spinners Limited, and Swaraj Suiting Limited following unusual trading activity. In some cases, there has been a significant increase in trading volume, while in others, there have been sharp rises or falls in share prices, and responses from several companies are still awaited.

Copies of clarifications from C.E. Info Systems Limited and Hinduja Global Solutions Limited have been made available on the NSE website. Hinduja Global Solutions Limited was also contacted by the exchange on July 14, 2026, and the July 15 update includes further details of that process.

Media Report Verification and Market Impact

Regarding IDBI Bank, a media report emerged that the government is close to accepting Fairfax Financial's revised proposal, after which the exchange wrote to the company to clarify the factual position. Similarly, verification was sought on reports regarding Instamart and HPCL's partnership for LPG cylinder delivery via quick commerce, Tata Motors and UCO Bank's commercial vehicle financing partnership, and the Delhi High Court's interim injunction on Zydus Cancer Drug Ikra.

The aim of these actions is to provide investors with the latest relevant information and maintain transparency in the market. Where clarifications are available, the exchange has made them public in the corporate filings and announcements section, while in other cases, investors are awaiting further company responses.

Our previous report on NSE seeking clarification from listed companies on media reports mentioned that the exchange had sent letters to Gensol Engineering, IDBI Bank, JSW Dulux, Shadowfax Technologies, and Zydus Lifesciences to protect investors' interests and verify the accuracy of information. The report highlighted requests for verification/responses regarding allegations against Gensol Engineering related to IREDA loans, proposals concerning IDBI Bank, and the court's interim order on Zydus's cancer drug Ikra.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.